Tashvinder Singh

Bathinda, PB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents.

Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents.

Journal: Journal of medicinal chemistry

Published: January 14, 2025

Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R Signaling.

Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R Signaling.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: October 21, 2024

Mitochondrial bioenergetics of breast cancer.

Mitochondrial bioenergetics of breast cancer.

Journal: Mitochondrion

Published: April 14, 2024

Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor.

Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor.

Journal: RSC medicinal chemistry

Published: April 07, 2024

Gene Expression Analysis in T2DM and Its Associated Microvascular Diabetic Complications: Focus on Risk Factor and RAAS Pathway.

Gene Expression Analysis in T2DM and Its Associated Microvascular Diabetic Complications: Focus on Risk Factor and RAAS Pathway.

Journal: Molecular neurobiology

Published: January 24, 2024

Comprehensive analysis of culture conditions governing differentiation of MSCs into articular chondrocytes.

Comprehensive analysis of culture conditions governing differentiation of MSCs into articular chondrocytes.

Journal: Regenerative medicine

Published: May 18, 2023

Trehalose and its Diverse Biological Potential.

Trehalose and its Diverse Biological Potential.

Journal: Current protein & peptide science

Published: February 11, 2023

Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.

Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.

Journal: Medical oncology (Northwood, London, England)

Published: February 01, 2023

In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice.

In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice.

Journal: Molecules (Basel, Switzerland)

Published: August 08, 2022

Differential molecular mechanistic behavior of HDACs in cancer progression.

Differential molecular mechanistic behavior of HDACs in cancer progression.

Journal: Medical oncology (Northwood, London, England)

Published: May 19, 2022

Design, synthesis and anticancer activity of 2-arylimidazo[1,2-a]pyridinyl-3-amines.

Design, synthesis and anticancer activity of 2-arylimidazo[1,2-a]pyridinyl-3-amines.

Journal: Bioorganic chemistry

Published: August 09, 2021

Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment.

Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment.

Journal: Molecules (Basel, Switzerland)

Published: January 10, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026